NCT05698992 Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer
| NCT ID | NCT05698992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Esophageal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-02-27 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-02-27 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and evaluate a model for systematic and evidence-based cancer rehabilitation for people with esophageal and gastric cancer to provide conditions for a better quality of life and fewer cancer-related symptoms.
Eligibility Criteria
Inclusion Criteria: * over 18 years of age * esophageal or gastric cancer * living in Southern Sweden (Skåne) * are planned to undergo curative surgerytreatment at Skåne University Hospital. Exclusion Criteria: * unable to communicate in the Swedish language * suffering from a cognitive impairment that poses a barrier for participating in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05698992 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05698992 currently recruiting?
Yes, NCT05698992 is actively recruiting participants. Contact the research team at wenche.melander@skane.se for enrollment information.
Where is the NCT05698992 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT05698992 clinical trial?
NCT05698992 is sponsored by Region Skane. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.